Developing and testing a smoking cessation app in Arabic language: A pilot randomized trial study protocol
Ola Soudah1, Mo'men Aldalal'ah1, Alameen Alsabbah1
1Faculty of Medicine, Yarmouk University, Irbid, Jordan.
Digital Health
|September 15, 2025
Summary
A new Arabic smoking cessation app, iEndSmokin, was developed to address high tobacco use in the Middle East. This pilot study will assess its feasibility and efficacy in helping adults quit smoking.
Area of Science:
- Public Health
- Digital Health
- Behavioral Science
Background:
- High tobacco consumption rates in the Middle East necessitate region-specific smoking cessation interventions.
- Existing Arabic smoking cessation apps are often direct translations and lack cultural adaptation, limiting their effectiveness.
- Culturally insensitive digital health tools fail to address unique regional needs for smoking cessation.
Purpose of the Study:
- To develop and evaluate the feasibility and efficacy of a culturally tailored Arabic smoking cessation mobile application, iEndSmokin (أنهيت التدخين).
- To integrate evidence-based strategies including the 5As, 5Rs, and cognitive behavioral therapy into the app.
- To provide a free, accessible, and clinically guided tool for Arabic-speaking smokers aiming to quit.
Main Methods:
- A pilot randomized controlled trial involving 200 adult smokers willing to quit, randomized 1:1 to the iEndSmokin app or educational sessions.
- A 3-month intervention period with a 6-month follow-up, including assessments at baseline, 1, 3, and 6 months.
- Intention-to-treat analysis will be employed for data evaluation.
Main Results:
- The primary outcome is 30-day point prevalence abstinence confirmed by saliva cotinine levels at 3 months.
- Secondary outcomes include 7-day point prevalence abstinence and a ≥20% reduction in smoking rate, both biochemically verified.
- Long-term smoking cessation will be assessed at the 6-month follow-up.
Conclusions:
- The iEndSmokin app represents a promising, low-cost approach to promote behavioral change in smoking cessation among Arabic speakers.
- The study hypothesizes that iEndSmokin will prove effective, accessible, and feasible for its target population.
- Clinical Trial Registration: NCT06766227.


